Looks like you have JavaScript disabled. For the full Twine experience, you will need to re-enable it.

Hi, I'm Harry Chrimes, Investment Manager at LYVA Labs, an early-stage health and life sciences impact investor based in the Liverpool City Region. I have nearly four years’ experience in investment and M&A, leading end-to-end due diligence, negotiating terms, and supporting portfolio companies from pre-seed to seed rounds. I enjoy connecting with founders through ecosystem networks, building financial models, and delivering investment readiness programs in incubators and accelerators. I’m passionate about turning breakthrough life sciences and deep-tech ideas into sustainable businesses that improve patient outcomes and deliver economic impact.…Hi, I'm Harry Chrimes, Investment Manager at LYVA Labs, an early-stage health and life sciences impact investor based in the Liverpool City Region. I have nearly four years’ experience in investment and M&A, leading end-to-end due diligence, negotiating terms, and supporting portfolio companies from pre-seed to seed rounds. I enjoy connecting with founders through ecosystem networks, building financial models, and delivering investment readiness programs in incubators and accelerators. I’m passionate about turning breakthrough life sciences and deep-tech ideas into sustainable businesses that improve patient outcomes and deliver economic impact.

Harry Chrimes

Project Manager, Content Producer, Executive Producer, +2





Hi, I'm Harry Chrimes, Investment Manager at LYVA Labs, an early-stage health and life sciences impact investor based in the Liverpool City Region. I have nearly four years’ experience in investment and M&A, leading end-to-end due diligence, negotiating terms, and supporting portfolio companies from pre-seed to seed rounds. I enjoy connecting with founders through ecosystem networks, building financial models, and delivering investment readiness programs in incubators and accelerators. I’m passionate about turning breakthrough life sciences and deep-tech ideas into sustainable businesses that improve patient outcomes and deliver economic impact.…Hi, I'm Harry Chrimes, Investment Manager at LYVA Labs, an early-stage health and life sciences impact investor based in the Liverpool City Region. I have nearly four years’ experience in investment and M&A, leading end-to-end due diligence, negotiating terms, and supporting portfolio companies from pre-seed to seed rounds. I enjoy connecting with founders through ecosystem networks, building financial models, and delivering investment readiness programs in incubators and accelerators. I’m passionate about turning breakthrough life sciences and deep-tech ideas into sustainable businesses that improve patient outcomes and deliver economic impact.

Available to hire

Hi, I’m Harry Chrimes, Investment Manager at LYVA Labs, an early-stage health and life sciences impact investor based in the Liverpool City Region. I have nearly four years’ experience in investment and M&A, leading end-to-end due diligence, negotiating terms, and supporting portfolio companies from pre-seed to seed rounds.

I enjoy connecting with founders through ecosystem networks, building financial models, and delivering investment readiness programs in incubators and accelerators. I’m passionate about turning breakthrough life sciences and deep-tech ideas into sustainable businesses that improve patient outcomes and deliver economic impact.

Skills

Experience Level

Expert

Expert

Expert

Expert

Expert

Expert

Language

English

Fluent

Work Experience

Duty Manager at Two Thirds Beer Co

September 1, 2021 - March 1, 2022

Duty Manager of Sheffield’s top-rated bar; led a team of 14, delivering strong financial results, outstanding guest experience, and 100% staff retention.

M&A Junior Associate (Warranty & Indemnity Insurance Broker) at Lockton Transactional Risks

April 1, 2022 - September 1, 2023

Managed flow of legal documentation, reviewed Information Memorandums and SPAs, analyzed due diligence reports, identified issues, and supported insurers and clients through final deal stages; contributed to business development.

Investment Manager at LYVA Labs

October 1, 2023 - Present

Sourced and due diligence early-stage health & life sciences and deep-tech opportunities; led end-to-end investment process, including term sheets, syndication, governance, portfolio management, and board observer duties.

Board Observer at Spotlight Pathology

July 1, 2024 - Present

Board observer from Pre-MVP to first commercial contracts; supported governance setup and seed round activity, culminating in £1.4m seed round in January 2026.

Board Observer at Medco Technologies

July 1, 2025 - Present

Supported setting up the board governance and seed raise; observed as part of LYVA Labs portfolio activity.